Back to MW MARSHALL WACE, LLP

SAVASAVA

Showing 7 of 17 quarters

Position history for MWMARSHALL WACE, LLP's holdings in FILANA THERAPEUTICS INC

Yes. Marshall Wace holds 1,597,548 shares of SAVA (Filana Therapeutics), worth $1.9M, as of its Q2 2026 13F filing. It reduced the position by 414,995 shares (-20.6%) from Q1 2026. Marshall Wace has held SAVA since Q2 2025, across 5 quarterly 13F filings.

Current Value

$1.9M

Current Shares

1.6M

Total Value Change

+$1.9M

Total Shares Change

+1.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.6M
-20.6%
$1.9M0.0%$1.19
0
2026-Q1
Decreased
2M
-4.9%
$3.4M0.0%$1.69
0
2025-Q4
Increased
2.1M
+2.6%
$4.2M0.0%$1.98
27
2025-Q3
Increased
2.1M
+2774.3%
$6M0.0%$2.91
44
2025-Q2
New
71,714
—
$129,8030.0%$1.81
31
2025-Q1
Exited
0
-100.0%
$00.0%$1.50
0
2024-Q4
New
21,093
—
$49,7790.0%$2.36
28

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used